Is Catalyst Biosciences Inc (CBIO) Stock Worth a Buy Friday?
Friday, December 17, 2021 10:46 AM | InvestorsObserver Analysts
Mentioned in this article
Catalyst Biosciences Inc (CBIO) stock is lower by -85.38% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CBIO stock a score of 34 out of a possible 100.
That rank is influenced by a long-term technical score of 0. CBIO's rank also includes a short-term technical score of 11. The fundamental score for CBIO is 92. In addition to the average rating from Wall Street analysts, CBIO stock has a mean target price of $9.50. This means analysts expect the stock to rise 840.59% over the next 12 months.
CBIO has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CBIO!
Catalyst Biosciences Inc (CBIO) stock is unmoved 0.5% while the S&P 500 is lower by -1.19% as of 10:29 AM on Friday, Dec 17. CBIO is unchanged $0.00 from the previous closing price of $1.01 on volume of 4,485,518 shares. Over the past year the S&P 500 has gained 23.92% while CBIO is lower by -85.38%. CBIO lost -$3.09 per share in the over the last 12 months.
Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
